05 Sep 2019 by admin in UncategorizedComments Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer
04 Sep 2019 by admin in UncategorizedComments Centrexion Therapeutics Announces CNTX-4975, CNTX-6970 and CNTX-6016 Data Presentations at PAINWeek 2019 National Conference
01 Aug 2019 by admin in UncategorizedComments Syros Reports Second Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
25 Jul 2019 by admin in UncategorizedComments Syros to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019
23 Jul 2019 by admin in UncategorizedComments resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness
